relapsed t-cell lymphoma Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 2 (1)

Interventional (1)

Wake Forest University Health Sciences (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadhodgkin lymphoma

I am/have/hadnon-hodgkin lymphoma

I am/have/hadmycosis fungoides/sezary syndrome

I am/have/hadrelapsed t-cell lymphoma

I am/have/hadt-cell lymphoma

I am/have/hadabsolute neutrophil count

I am/have/hadmycosis fungoides

I am/have/hadlymphoma

I am/have/hadultraviolet light therapy

I am/have/hadrenal function test

I am/have/hadmycosis fungoides and sezary syndrome

I am/have/hadmetastatic cancer

I am/have/hadneutrophil count

I am/have/hadinfertility

I am/have/hadcutaneous t cell lymphoma

I am/have/hadperipheral t-cell lymphoma

I am/have/hadcutaneous t-cell lymphoma

I am/have/hadsystemic therapy

I am/have/hadhodgkin's disease

I am/have/hadliver metastasis

added new label for I am/have/had

more

I am looking for

I am looking forchemotherapy drugs

I am looking fororal contraceptives

I am looking forpsoralen

I am looking forbendamustine

I am looking forbrentuximab vedotin

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Hematology
Recruiting

CPI-613 in Combination With Bendamustine in Patients With Relapsed/Refractory T-Cell Non-Hodgkin Lymphoma

The purpose of this study is to determine if it is possible to give CPI-613 with the drug Bendamustine for 2 days every 28 days without causing severe side effects. In addition, this study will also test the safety of CPI-613 when given in combination with Bendamustine.

hodgkin lymphoma

non-hodgkin lymphoma

relapsed t-cell lymphoma

mycosis fungoides/sezary syndrome

t-cell lymphoma

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.